The methodology involved a comparative analysis of methylation levels at a specific CpG dinucleotide within the SPDEF promoter region (chr6:34544344–34544482) in DNA extracted from whole blood leukocytes of PCa patients and BPH controls. This evidence concerns the gene SPDEF and posterior cortical atrophy.